Revitalization of Damaged Skin Due to Chronic Skin Diseases

ACE Cells Lab

Status and phase: Unknown; Early Phase 1

Conditions: Atopic Dermatitis; Psoriasis; Chronic Eczema

Treatments: Combination Product: ACE CSD

Study type: Interventional

Funder types: Industry

Identifiers

NCT03485560

ACEcsd

Details and patient eligibility

About

Chronic skin disease lead to skin damage and disfiguring to the patient skin. Sometimes, achieving normal skin is not possible by the normal traditional treatment, this study is focusing on use of ACE CSD formula which is mixture of natural peptides and herbs. the main aim is to restore the normal skin appearance for the patient and control the episodes of flare.

Full description

Psoriasis is a chronic, immune mediated (type 2 and type 17) chronic skin disease. The production of the immune proteins that leads to continuous inflammatory mediated process. The result of chronic inflammation is they hyper keratotic layer of skin which gets attacks of atopic dermatitis leading to symptoms of itching, pruritis and in situ bleeding.

ACE CSD, with the multiple factors that mediates the immune response and control the protein receptors, in addition to the multiple regeneration peptides that are specifically extracted from healthy skin of newly born sheep; in addition to multiple Chinese herbs that contains different anabolic factors was tested to be able to regenerate the damaged skin and locally modulate the immunity reactions so the skin can regenerate fully to replace the damaged skin with normal healthy skin.

Enrollment: 200 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Chronic skin condition lasts for more than 1 year.
• tried traditional treatment with limited or without effect.
• not on steroids for at least 6 weeks.

Exclusion criteria

• patients on steroid.
• patients intolerable to protein or allergic to proteins
• during pregnancy or lactation

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

200 participants in 1 patient group

internvention of Chrinic skin conditions

Experimental group

Description:

All cases of chronic skin conditions will be included to measure the effect on the 3 of them and whihc one will respond to the treatment better

Treatment:

Combination Product: ACE CSD